Cell Impact 관리

관리 기준 확인 1/4

Cell Impact CEO는 Daniel Vallin, Jan2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 SEK 96.29K 가치에 해당하는 회사 주식의 0.077% 직접 소유합니다. 96.29K. 경영진과 이사회의 평균 재임 기간은 각각 2 년과 1.6 년입니다.

주요 정보

Daniel Vallin

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	0.08%
경영진 평균 재임 기간	2yrs
이사회 평균 재임 기간	1.6yrs

최근 관리 업데이트

Recent updates

Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?

May 13

Is Cell Impact (STO:CI) Using Debt In A Risky Way?

Jan 14

Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation

May 09

Investors Who Bought Cell Impact (STO:CI B) Shares Three Years Ago Are Now Up 428%

Feb 21

How Much Is Cell Impact AB (publ) (STO:CI B) Paying Its CEO?

Dec 27

CEO

Daniel Vallin (47 yo)

less than a year

테뉴어

Mr. Daniel Vallin serves as Chief Executive Officer since October 1, 2024 and served as its Acting Chief Executive Officer since January 1, 2024 until October 1, 2024 and was Chief Operating Officer at Cel...

리더십 팀

이름	위치	테뉴어	보상	소유권
Daniel Vallin	Chief Executive Officer	less than a year	데이터 없음	0.077% SEK 96.3k
Malin Lundberg	Chief Financial Officer	less than a year	데이터 없음	데이터 없음
Anders Öberg	Chief Technology Officer	6.8yrs	데이터 없음	데이터 없음
Marcus Nilsson	Sales & Program Manager	no data	데이터 없음	데이터 없음
Karina Larsson	Chief Human Resource Officer	3.2yrs	데이터 없음	0.0023% SEK 2.9k
Shigeru Nakagawa	Managing Director of Cell Impact Japan Inc.	3.8yrs	데이터 없음	0.016% SEK 19.5k
Henrik Jackman	Chief Application Engineer	less than a year	데이터 없음	데이터 없음

2.0yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: CI 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Thomas Carlstrom	Director	7.8yrs	SEK 86.00k	0.078% SEK 97.2k
Mats Boquist	Director	less than a year	데이터 없음	데이터 없음
Mats Franzén	Chairman of the Board	1.6yrs	데이터 없음	0.29% SEK 357.3k
Lars Bergstrom	Director	2.8yrs	데이터 없음	0.15% SEK 189.0k
Jan Pieters	Director	less than a year	데이터 없음	데이터 없음

1.6yrs

평균 재임 기간

68yo

평균 연령

경험이 풍부한 이사회: CI 의 이사회는 경험(평균 재직 기간 1.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Cell Impact 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Chairman of the Board exercised options to buy kr76k worth of stock.

Cell Impact AB (Publ) Announces Daniel Vallin as the Permanent CEO, Effective from October 1, 2024

Director recently bought kr125k worth of stock

Cell Impact AB (Publ) Announces Board and Committee Changes

Director recently bought kr91k worth of stock

Cell Impact AB (Publ) Appoints Henrik Jackman as Chief Application Engineer

Recent updates

Cell Impact AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025

Chairman of the Board exercised options to buy kr76k worth of stock.

Cell Impact AB (Publ) Announces Daniel Vallin as the Permanent CEO, Effective from October 1, 2024

Director recently bought kr125k worth of stock

Second quarter 2024 earnings released

Cell Impact AB (Publ) Provides Earnings Guidance for the Year 2027 and 2030

Cell Impact Adds Sealing as A New Part of Production Process

New major risk - Share price stability

First quarter 2024 earnings released: kr0.04 loss per share (vs kr0.40 loss in 1Q 2023)

Cell Impact AB (Publ) Announces Board and Committee Changes

Director recently bought kr91k worth of stock

Full year 2023 earnings released: kr1.11 loss per share (vs kr1.38 loss in FY 2022)

Cell Impact AB (Publ) Appoints Henrik Jackman as Chief Application Engineer

Chief Executive Officer recently bought kr50k worth of stock

Cell Impact AB (publ) Announces CEO Changes

New major risk - Shareholder dilution

Cell Impact AB (Publ) Announces That Stefan Axellie to Leave Role as CFO

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.38 loss in 3Q 2022)

Cell Impact AB (Publ) Announces Preliminary Earnings Guidance for Third Quarter 2023

New major risk - Market cap size

Cell Impact AB (publ) Announces Anna Frick Will Leave the Board

Chief Executive Officer recently bought kr101k worth of stock

Cell Impact AB (publ) Provides Earnings Guidance for the Year 2025 and 2028

Cell Impact AB (Publ) Announces Outstanding Measuring Precision Enabling Customers' Product Development

New major risk - Share price stability

Chief Executive Officer recently bought kr50k worth of stock

Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?

Full year 2022 earnings released: kr1.38 loss per share (vs kr1.35 loss in FY 2021)

Cell Impact AB (publ) to Report Fiscal Year 2023 Results on Mar 24, 2024

Is Cell Impact (STO:CI) Using Debt In A Risky Way?

No independent directors

Third quarter 2022 earnings released: kr0.38 loss per share (vs kr0.25 loss in 3Q 2021)

Second quarter 2022 earnings released

Cell Impact AB (publ) PUBL SHARE AK B to Be Deleted from Other OTC

First quarter 2022 earnings released

No independent directors

Full year 2021 earnings released: kr1.35 loss per share (vs kr0.88 loss in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Cell Impact AB (publ) to Report Q2, 2022 Results on Aug 25, 2022

Third quarter 2021 earnings released

Second quarter 2021 earnings released

Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation

First quarter 2021 earnings released

Cell Impact AB (publ) Receives SEK 42 Million Order from Plug Power for New Production Line and Flow Plates

Investors Who Bought Cell Impact (STO:CI B) Shares Three Years Ago Are Now Up 428%

Full year 2020 earnings released: kr0.85 loss per share (vs kr1.45 loss in FY 2019)

New 90-day high: kr49.70

Cell Impact Appoints Forrest Zhang as Country Manager in China, Effective May 3, 2021

How Much Is Cell Impact AB (publ) (STO:CI B) Paying Its CEO?

New 90-day high: kr29.30

New 90-day high: kr29.00

Third quarter 2020 earnings released: kr0.12 loss per share

New 90-day low: kr21.35

Cell Impact AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 175 million.

First half earnings released

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령